Literature DB >> 29211830

Antibiotic Utilization and the Role of Suspected and Diagnosed Mosquito-borne Illness Among Adults and Children With Acute Febrile Illness in Pune, India.

Matthew L Robinson1, Dileep Kadam2,3, Anju Kagal2,3, Sandhya Khadse2,3, Aarti Kinikar2,3, Chhaya Valvi2,3, Anita Basavaraj2,3, Renu Bharadwaj2,3, Ivan Marbaniang3, Savita Kanade3, Priyanka Raichur3, Jonathan Sachs4, Eili Klein5,6,7,8, Sara Cosgrove1, Amita Gupta1,3,5, Vidya Mave1,3.   

Abstract

Background: Antibiotic resistance mechanisms originating in low- and middle- income countries are among the most common worldwide. Reducing unnecessary antibiotic use in India, the world's largest antibiotic consumer, is crucial to control antimicrobial resistance globally. Limited data describing factors influencing Indian clinicians to start or stop antibiotics are available.
Methods: Febrile adults and children admitted to a public tertiary care hospital in Pune, India, were enrolled. Antibiotic usage and clinical history were recorded. Immunoassays for mosquito-borne disease and bacterial cultures were performed by protocol and clinician-directed testing. Clinical factors were assessed for association with empiric antibiotic initiation and discontinuation by day 5 using multivariable logistic regression and propensity score-matched Cox proportional hazard models.
Results: Among 1486 participants, 683 (82%) adults and 614 (94%) children received empiric antibiotics. Participants suspected of having mosquito-borne disease were less likely to receive empiric antibiotics (adjusted odds ratio [AOR], 0.5; 95% confidence interval [CI], .4-.8). Empiric antibiotics were discontinued in 450 (35%) participants by day 5. Dengue or malaria testing performed before day 4 was positive in 162 (12%) participants, and was associated with antibiotic discontinuation (AOR, 1.7; 95% CI, 1.2-2.4). In a propensity score-matched model accounting for admission suspicion of mosquito-borne disease, positive dengue or malaria tests increased hazard of antibiotic discontinuation (hazard ratio, 1.6; 95% CI, 1.2-2.0). Conclusions: Most patients with acute febrile illness in an Indian public hospital setting receive empiric antibiotics. Mosquito-borne disease identification is associated with reduced empiric antibiotic use and faster antibiotic discontinuation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29211830      PMCID: PMC5930254          DOI: 10.1093/cid/cix1059

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  Antimicrobial drug use in a small Indian community hospital.

Authors:  M Blomberg; M Blomberg Jensen; A Henry; S T Singh; R P Singh Banipal; C da Cunha-Bang; I C Bygbjerg
Journal:  Trop Doct       Date:  2010-10       Impact factor: 0.731

Review 2.  Better tests, better care: improved diagnostics for infectious diseases.

Authors:  Angela M Caliendo; David N Gilbert; Christine C Ginocchio; Kimberly E Hanson; Larissa May; Thomas C Quinn; Fred C Tenover; David Alland; Anne J Blaschke; Robert A Bonomo; Karen C Carroll; Mary Jane Ferraro; Lisa R Hirschhorn; W Patrick Joseph; Tobi Karchmer; Ann T MacIntyre; L Barth Reller; Audrey F Jackson
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

3.  Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.

Authors:  Thomas P Van Boeckel; Sumanth Gandra; Ashvin Ashok; Quentin Caudron; Bryan T Grenfell; Simon A Levin; Ramanan Laxminarayan
Journal:  Lancet Infect Dis       Date:  2014-07-09       Impact factor: 25.071

4.  Evaluation of two new immunochromatographic assays for diagnosis of malaria.

Authors:  Arsène Ratsimbasoa; Laza Fanazava; Rogelin Radrianjafy; Julien Ramilijaona; Hughes Rafanomezantsoa; Didier Ménard
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

5.  Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.

Authors:  Stephen P Hawser; Samuel K Bouchillon; Daryl J Hoban; Robert E Badal; Po-Ren Hsueh; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

6.  Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks.

Authors:  Grace Yap; Kwoon-Yong Pok; Yee-Ling Lai; Hapuarachchige-Chanditha Hapuarachchi; Angela Chow; Yee-Sin Leo; Li-Kiang Tan; Lee-Ching Ng
Journal:  PLoS Negl Trop Dis       Date:  2010-07-20

7.  Rationalizing antibiotic use to limit antibiotic resistance in India.

Authors:  Nirmal K Ganguly; N K Arora; Sujith J Chandy; Mohamed Nadeem Fairoze; J P S Gill; Usha Gupta; Shah Hossain; Sadhna Joglekar; P C Joshi; Manish Kakkar; Anita Kotwani; Ashok Rattan; H Sudarshan; Kurien Thomas; Chand Wattal; Alice Easton; Ramanan Laxminarayan
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

8.  Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings.

Authors:  Heidi Hopkins; Katia J Bruxvoort; Matthew E Cairns; Clare I R Chandler; Baptiste Leurent; Evelyn K Ansah; Frank Baiden; Kimberly A Baltzell; Anders Björkman; Helen E D Burchett; Siân E Clarke; Deborah D DiLiberto; Kristina Elfving; Catherine Goodman; Kristian S Hansen; S Patrick Kachur; Sham Lal; David G Lalloo; Toby Leslie; Pascal Magnussen; Lindsay Mangham Jefferies; Andreas Mårtensson; Ismail Mayan; Anthony K Mbonye; Mwinyi I Msellem; Obinna E Onwujekwe; Seth Owusu-Agyei; Hugh Reyburn; Mark W Rowland; Delér Shakely; Lasse S Vestergaard; Jayne Webster; Virginia L Wiseman; Shunmay Yeung; David Schellenberg; Sarah G Staedke; Christopher J M Whitty
Journal:  BMJ       Date:  2017-03-29

9.  The global distribution and burden of dengue.

Authors:  Samir Bhatt; Peter W Gething; Oliver J Brady; Jane P Messina; Andrew W Farlow; Catherine L Moyes; John M Drake; John S Brownstein; Anne G Hoen; Osman Sankoh; Monica F Myers; Dylan B George; Thomas Jaenisch; G R William Wint; Cameron P Simmons; Thomas W Scott; Jeremy J Farrar; Simon I Hay
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

10.  Performance of commercial dengue NS1 ELISA and molecular analysis of NS1 gene of dengue viruses obtained during surveillance in Indonesia.

Authors:  Aryati Aryati; Hidayat Trimarsanto; Benediktus Yohan; Puspa Wardhani; Sukmal Fahri; R Tedjo Sasmono
Journal:  BMC Infect Dis       Date:  2013-12-29       Impact factor: 3.090

View more
  5 in total

1.  Impact of Dengue Rapid Diagnostic Tests on the Prescription of Antibiotics and Anti-Inflammatory Drugs by Physicians in an Endemic Area in Colombia.

Authors:  María Elena Tello-Cajiao; Lyda Osorio
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

2.  Antibiotic Use before, during, and after Seeking Care for Acute Febrile Illness at a Hospital Outpatient Department: A Cross-Sectional Study from Rural India.

Authors:  Bronwen Holloway; Harshitha Chandrasekar; Manju Purohit; Ashish Sharma; Aditya Mathur; Ashish Kc; Leticia Fernandez-Carballo; Sabine Dittrich; Helena Hildenwall; Anna Bergström
Journal:  Antibiotics (Basel)       Date:  2022-04-25

3.  A systematic review of antimicrobial resistance of typhoidal Salmonella in India.

Authors:  Carl D Britto; Jacob John; Valsan P Verghese; Andrew J Pollard
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

4.  Population-based assessment of factors influencing antibiotic prescribing for adults with dengue infection in Taiwan.

Authors:  Chia-En Lien; Yiing-Jenq Chou; Yi-Jung Shen; Theodore Tsai; Nicole Huang
Journal:  PLoS Negl Trop Dis       Date:  2022-02-28

Review 5.  Antimicrobial Stewardship in Tropical Infectious Diseases: Focusing on Dengue and Malaria.

Authors:  Ashley Siribhadra; Thundon Ngamprasertchai; Pinyo Rattanaumpawan; Saranath Lawpoolsri; Viravarn Luvira; Punnee Pitisuttithum
Journal:  Trop Med Infect Dis       Date:  2022-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.